CP
Ceruloplasmin
Also known as: AB073614, CERU_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P00450
- Gene
- CP
- Ensembl
- ENSG00000047457
- Chromosome
- 3
- Canonical length
- 1065 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
1065 residues, UniProt reviewed canonical sequence.
>P00450|CP
1 MKILILGIFL FLCSTPAWAK EKHYYIGIIE TTWDYASDHG EKKLISVDTE HSNIYLQNGP
61 DRIGRLYKKA LYLQYTDETF RTTIEKPVWL GFLGPIIKAE TGDKVYVHLK NLASRPYTFH
121 SHGITYYKEH EGAIYPDNTT DFQRADDKVY PGEQYTYMLL ATEEQSPGEG DGNCVTRIYH
181 SHIDAPKDIA SGLIGPLIIC KKDSLDKEKE KHIDREFVVM FSVVDENFSW YLEDNIKTYC
241 SEPEKVDKDN EDFQESNRMY SVNGYTFGSL PGLSMCAEDR VKWYLFGMGN EVDVHAAFFH
301 GQALTNKNYR IDTINLFPAT LFDAYMVAQN PGEWMLSCQN LNHLKAGLQA FFQVQECNKS
361 SSKDNIRGKH VRHYYIAAEE IIWNYAPSGI DIFTKENLTA PGSDSAVFFE QGTTRIGGSY
421 KKLVYREYTD ASFTNRKERG PEEEHLGILG PVIWAEVGDT IRVTFHNKGA YPLSIEPIGV
481 RFNKNNEGTY YSPNYNPQSR SVPPSASHVA PTETFTYEWT VPKEVGPTNA DPVCLAKMYY
541 SAVEPTKDIF TGLIGPMKIC KKGSLHANGR QKDVDKEFYL FPTVFDENES LLLEDNIRMF
601 TTAPDQVDKE DEDFQESNKM HSMNGFMYGN QPGLTMCKGD SVVWYLFSAG NEADVHGIYF
661 SGNTYLWRGE RRDTANLFPQ TSLTLHMWPD TEGTFNVECL TTDHYTGGMK QKYTVNQCRR
721 QSEDSTFYLG ERTYYIAAVE VEWDYSPQRE WEKELHHLQE QNVSNAFLDK GEFYIGSKYK
781 KVVYRQYTDS TFRVPVERKA EEEHLGILGP QLHADVGDKV KIIFKNMATR PYSIHAHGVQ
841 TESSTVTPTL PGETLTYVWK IPERSGAGTE DSACIPWAYY STVDQVKDLY SGLIGPLIVC
901 RRPYLKVFNP RRKLEFALLF LVFDENESWY LDDNIKTYSD HPEKVNKDDE EFIESNKMHA
961 INGRMFGNLQ GLTMHVGDEV NWYLMGMGNE IDLHTVHFHG HSFQYKHRGV YSSDVFDIFP
1021 GTYQTLEMFP RTPGIWLLHC HVTDHIHAGM ETTYTVLQNE DTKSGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.2
- Highest tissue expression
- 1,750 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,750 nTPM
- choroid plexus: 411 nTPM
- retina: 228 nTPM
- cervix: 66 nTPM
- blood vessel: 62 nTPM
- heart muscle: 40 nTPM
Single-cell type
- hepatocytes: 1,511 nCPM
- pituicytes/fscs: 899 nCPM
- müller glia: 757 nCPM
- conjunctival goblet cells: 649 nCPM
- endometrial secretory cells: 591 nCPM
- endometrial glandular cells: 522 nCPM
Immune cell
- naive B-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 228 nTPM
- hypothalamus: 45 nTPM
- white matter: 31 nTPM
- medulla oblongata: 30 nTPM
- pons: 18 nTPM
- midbrain: 17 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CP.
Disease | AllUniProt
Conditions CP is implicated in, by any mechanism.
- Aceruloplasminemia (ACEP) MIM:604290
Disease | GeneticClinVar
99 pathogenic / likely-pathogenic of 784 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Deficiency of ferroxidase
- Neurodegeneration with brain iron accumulation
- CP-related disorder
- Inborn genetic diseases
- Thyroid cancer, nonmedullary, 1
Disease | ImmuneIEDB
Conditions an epitope on CP was assayed in.
- rheumatoid arthritis B cell
ReferencesPubMed · IEDB
Publications for CP from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases.
1998 · Clin Exp Immunol · RCR 1.9 · 68 citations
Reference: B cellIEDB
1 publication
- Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
2020 · Arthritis Rheumatol · RCR 1.7 · 30 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.22
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- copper ion binding
- ferroxidase activity
- glutathione peroxidase activity
- oxidoreductase activity
- phospholipid-hydroperoxide glutathione peroxidase activity
- protein-folding chaperone binding
- oxidoreductase activity, acting on metal ions, oxygen as acceptor
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Multicopper oxidase, copper-binding site
- Cupredoxin
- Multicopper oxidase, C-terminal
- Multicopper oxidase-like, N-terminal
- Multicopper oxidases, conserved site
- Multicopper oxidase
- Ceruloplasmin-like, fifth cupredoxin domain
- Multicopper oxidase
- Multicopper oxidase
- Multicopper oxidase, second cupredoxin domain
- Multicopper oxidase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CP as an antibody target. Whether an autoantibody or antibody against CP could matter depends on whether native CP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CP is annotated as secreted, so native CP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...